Gingival fibroepithelial polyp

Summary

Gingival fibroepithelial polyp (MONDO:0060768) is a disease. A subtype of epulis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	gingival fibroepithelial polyp
Mondo ID	MONDO:0060768
ICD-11	1520492305
NCIT	C4693
SNOMED CT	235001002
UMLS	C0399441
MedGen	98314
Anatomy (UBERON)	UBERON:0001828
Is cancer (heuristic)	no

Also known as: fibroepithelial polyp of gingiva · fibroepithelial polyp of gum · fibroepithelial polyp of the gingiva · fibroepithelial polyp of the gum · gingival fibroepithelial polyp · gum fibroepithelial polyp

Disease family

This is a subtype of epulis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › musculoskeletal system disorder › skeletal system disorder › periodontal disorder › gingival disorder › gingival overgrowth › epulis › gingival fibroepithelial polyp

Related subtypes (1): congenital epulis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.